Zobrazeno 1 - 10
of 30
pro vyhledávání: '"M, Van der Straaten"'
Autor:
Sabine Haggenburg, Hannah M. Garcia Garrido, Iris M. J. Kant, Hanneke M. Van der Straaten, Fransien De Boer, Sabina Kersting, Djamila Issa, Doreen Te Raa, Hein P. J. Visser, Arnon P. Kater, Abraham Goorhuis, Koen De Heer
Publikováno v:
Vaccines, Vol 11, Iss 7, p 1201 (2023)
Patients with Chronic Lymphocytic Leukemia (CLL) have a 29- to 36-fold increased risk of invasive pneumococcal disease (IPD) compared to healthy adults. Therefore, most guidelines recommend vaccination with the 13-valent pneumococcal conjugated vacci
Externí odkaz:
https://doaj.org/article/c65a3f49f770442dbbaeaa02436e3d61
Autor:
Doreen G Te, Raa, Lina, van der Straten, Michel, van Gelder, Sabina, Kersting, Mark-David, Levin, Rogier, Mous, Hanneke M, van der Straaten, Marten R, Nijziel, Ellen, van der Spek, Eduardus F M, Posthuma, Hein P J, Visser, Marjolein, van der Klift, Koen, de Heer, Mar, Bellido, Jeanette K, Doorduijn, Anke H W, Bruns, Reinier A P, Raijmakers, Arnon P, Kater
Publikováno v:
HOVON CLL study group 2022, ' Diagnosis, treatment and supportive management of chronic lymphocytic leukemia : recommendations of the Dutch HOVON CLL working group ', Leukemia and Lymphoma, vol. 63, no. 10, pp. 2276-2289 . https://doi.org/10.1080/10428194.2022.2084731
Management of patients with chronic lymphocytic leukemia (CLL) is changing due to considerable advances in the therapeutic armamentarium, and new therapies will possibly continue to emerge in the near future. Therefore, the CLL working group of the D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfc5ffe46d9de15522c014f7cbb5f7ef
https://hdl.handle.net/11370/29686129-bbf3-41c9-8726-fd23f290d6e6
https://hdl.handle.net/11370/29686129-bbf3-41c9-8726-fd23f290d6e6
Autor:
Heer, Sabine Haggenburg, Hannah M. Garcia Garrido, Iris M. J. Kant, Hanneke M. Van der Straaten, Fransien De Boer, Sabina Kersting, Djamila Issa, Doreen Te Raa, Hein P. J. Visser, Arnon P. Kater, Abraham Goorhuis, Koen De
Publikováno v:
Vaccines; Volume 11; Issue 7; Pages: 1201
Patients with Chronic Lymphocytic Leukemia (CLL) have a 29- to 36-fold increased risk of invasive pneumococcal disease (IPD) compared to healthy adults. Therefore, most guidelines recommend vaccination with the 13-valent pneumococcal conjugated vacci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::5c517de9bc68bbefb122359713b49cd1
Autor:
Sabina Kersting, Julie Dubois, Kazem Nasserinejad, Johan A Dobber, Clemens Mellink, Anne-Marie F van der Kevie-Kersemaekers, Ludo M Evers, Fransien de Boer, Harry R Koene, John Schreurs, Marjolein van der Klift, Gerjo A Velders, Ellen van der Spek, Hanneke M van der Straaten, Mels Hoogendoorn, Michel van Gelder, Eduardus F M Posthuma, Hein P J Visser, Ilse Houtenbos, Cecile A M Idink, Djamila E Issa, Ellen C Dompeling, Henk C T van Zaanen, Hendrik Veelken, Henriette Levenga, Lidwine W Tick, Wim E Terpstra, Sanne H Tonino, Michelle Boyer, Mehrdad Mobasher, Mark-David Levin, Arnon P Kater
Publikováno v:
The Lancet Haematology, 9(3), e190-e199. Lancet Publishing Group
The Lancet Haematology, 9(3), E190-E199. ELSEVIER SCI LTD
The Lancet Haematology, 9(3), E190-E199. ELSEVIER SCI LTD
Background Fixed-duration 12 cycles of venetoclax plus obinutuzumab is established as first-line treatment for patients with chronic lymphocytic leukaemia. We aimed to determine the activity and safety of 12 cycles of venetoclax consolidation after f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0986e715312f80218fa9f8521d8b97ab
https://doi.org/10.1016/s2352-3026(22)00034-5
https://doi.org/10.1016/s2352-3026(22)00034-5
Autor:
Mirian Brink, Arie C. van der Spek, Koen de Heer, Sabina Kersting, Lidwine W. Tick, Hanneke M. van der Straaten, Rogier Mous, Mark-David Levin, Doreen te Raa, Michel van Gelder, Jeanette K. Doorduijn, Arnon P. Kater, Gerwin Huls, Mar Bellido
Publikováno v:
Blood. 140:3788-3789
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e71b1b332fee2756d5c21a137b17a23
https://doi.org/10.1182/blood-2022-168849
https://doi.org/10.1182/blood-2022-168849
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jacoline W. Brinkman, An K. Stroobants, Hanneke M. van der Straaten, Cornelis L. Harteveld, Kirsten M. Pondman
Publikováno v:
Hemoglobin, 42(1), 51-53
Hemoglobin, 42(1), 51-53. Informa Healthcare
Hemoglobin, 42(1), 51-53. Informa Healthcare
We report two families, members of which are carriers of a hemoglobin (Hb) variant previously described as Hb Nouakchott [α114(GH2)Pro→Leu; HBA1: c.344C>T; p.Pro115Leu]. In the first family of Dutch origin, the proband, a 32-year-old male and his
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1674a4d4f1d7f3f03d837e5b47250fa6
https://hdl.handle.net/1887/79401
https://hdl.handle.net/1887/79401
Autor:
Michel van Gelder, Arnon P. Kater, Rogier Mous, Hein Visser, Sabina Kersting, Ward Posthuma, Mark-David Levin, Hanneke M. van der Straaten, Suzanne I.M. Neppelenbroek
Publikováno v:
Clinical Lymphoma Myeloma & Leukemia, 18(1), 52-57. CIG Media Group, L.P.
Clinical lymphoma, myeloma & leukemia, 18(1), 52-57. Cancer Media Group
Clinical Lymphoma Myeloma and Leukemia, 18(1), 52-57. Cancer Media Group
Clinical lymphoma, myeloma & leukemia, 18(1), 52-57. Cancer Media Group
Clinical Lymphoma Myeloma and Leukemia, 18(1), 52-57. Cancer Media Group
Considerable progress has been made in treatment of patients with CLL, and new potent drugs have become available. Therefore the Dutch CLL guidelines were revised. Efficacy, quality of life and socio-economic impact were taken into account. This has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e9ddb866cbdf0da6fbd9e8f38370488
https://pubmed.ncbi.nlm.nih.gov/29097160
https://pubmed.ncbi.nlm.nih.gov/29097160
Autor:
Rob Fijnheer, Marijke R. Canninga-van Dijk, Leo F. Verdonck, Jan Aten, Hanneke M. van der Straaten, Domenico Castigliego, H.P. Eric Borst
Publikováno v:
Journal of investigative dermatology, 123(6), 1057-1062. Nature Publishing Group
One of the major complications that limit the success of allogeneic stem cell transplantation is graft-versus-host disease (GVHD). The major target organ in GVHD is the skin. Cutaneous GVHD can eventually lead to fibrosis of the skin. Fibronectin med
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b91b00cef077a7a0cb423b97d7ad21ca
https://doi.org/10.1111/j.0022-202x.2004.23474.x
https://doi.org/10.1111/j.0022-202x.2004.23474.x
Autor:
Leo F. Verdonck, Cornelus J. G. Sanders, Rob Fijnheer, Marijke R. Canninga-van Dijk, Hanneke M. van der Straaten, Jan G. van den Tweel
Publikováno v:
Blood. 104:2603-2606
Chronic graft-versus-host disease (cGVHD) is an important determinant of long-term morbidity and mortality in allogeneic stem cell transplantation patients. Because cGVHD has clinical, histologic, and laboratory findings of autoimmune diseases and an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fb3002861befab8048cc782c61ce471
https://doi.org/10.1182/blood-2004-05-1855
https://doi.org/10.1182/blood-2004-05-1855